The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.

High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment. World J Urol (2012) 0.97

Initial experience of combined use of photodynamic diagnosis and narrow band imaging for detection of flat urothelial lesion. Int J Clin Oncol (2014) 0.84

Immunological basis in the pathogenesis and treatment of bladder cancer. Expert Rev Clin Immunol (2014) 0.83

How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy? Investig Clin Urol (2016) 0.78

The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy. Onco Targets Ther (2016) 0.77

Transurethral Use of Evicel(®) Fibrin Sealant. Urol Case Rep (2015) 0.75

An uncommon manifestation of paraneoplastic cerebellar degeneration in a patient with high grade urothelial, carcinoma with squamous differentiation: A case report and literature review. BMC Cancer (2016) 0.75

The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer. BJU Int (2012) 0.75

Quality of transurethral resection of bladder tumor procedure influenced a phase III trial comparing the effect of KLH and mitomycin C. Trials (2017) 0.75

Transurethral En Bloc Resection of Bladder Tumor Using an Endoscopic Submucosal Dissection Technique: Preliminary Results in an Animal Model. Yonago Acta Med (2016) 0.75

Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24

Nephron number in patients with primary hypertension. N Engl J Med (2003) 6.74

Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A (2010) 5.05

Pathologic classification of diabetic nephropathy. J Am Soc Nephrol (2010) 3.61

Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature (2011) 3.61

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med (2008) 2.99

FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet (2012) 2.74

Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nat Med (2006) 2.59

B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. Blood (2010) 2.17

Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res (2009) 2.16

Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14

1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol (2003) 1.86

Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival. Eur Urol (2006) 1.86

Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure. J Am Soc Nephrol (2006) 1.86

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment. BMC Cancer (2011) 1.83

Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004) 1.81

Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am J Physiol Heart Circ Physiol (2002) 1.79

The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res (2010) 1.75

Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties. J Mol Cell Cardiol (2004) 1.72

Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2 -/- mice. Curr Biol (2002) 1.70

p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency. Kidney Int (2005) 1.67

Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis (2004) 1.64

Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. Hypertension (2008) 1.63

Nephron number, hypertension, renal disease, and renal failure. J Am Soc Nephrol (2005) 1.57

The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1. J Biol Chem (2009) 1.56

Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1. J Mol Med (Berl) (2006) 1.55

Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy? J Clin Oncol (2006) 1.53

Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res (2010) 1.51

Outcome of prostate cancer patients with initial PSA> or =20 ng/ml undergoing radical prostatectomy. Eur Urol (2007) 1.49

Factor inhibiting HIF limits the expression of hypoxia-inducible genes in podocytes and distal tubular cells. Kidney Int (2010) 1.49

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening. Int J Cancer (2011) 1.47

Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Med (2012) 1.45

No aggravation of renal injury in apolipoprotein E knockout mice (ApoE(-/-)) after subtotal nephrectomy. Nephrol Dial Transplant (2004) 1.45

Intrauterine growth restriction leads to a dysregulation of Wilms' tumour supressor gene 1 (WT1) and to early podocyte alterations. Nephrol Dial Transplant (2012) 1.44

Changes in 11beta-hydroxysteroid dehydrogenase type 2 expression in a low-protein rat model of intrauterine growth restriction. Nephrol Dial Transplant (2010) 1.40

Umbilical rotation: a new technique for the cutaneous fixation of continent catheterizable vesicostomies. J Pediatr Urol (2010) 1.40

Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol (2003) 1.39

The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma. Int J Cancer (2010) 1.29

Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project. BMC Genomics (2008) 1.29

CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. J Immunol (2010) 1.29

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis (2013) 1.28

The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol (2003) 1.26

HIF activation protects from acute kidney injury. J Am Soc Nephrol (2008) 1.25

Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. Circulation (2005) 1.24

Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol (2006) 1.22

Ultrastructural analysis of vascular calcifications in uremia. J Am Soc Nephrol (2010) 1.21

Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. Int Immunol (2006) 1.21

Do urology journals enforce trial registration? A cross-sectional study of published trials. BMJ Open (2011) 1.19

Estimating cancer survival and clinical outcome based on genetic tumor progression scores. Bioinformatics (2005) 1.18

Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Mol Cancer Res (2011) 1.17

Thrombotic microangiopathy: new insights. Curr Opin Nephrol Hypertens (2010) 1.17

Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo. Diabetes (2007) 1.15

Stimulation of GCMa and syncytin via cAMP mediated PKA signaling in human trophoblastic cells under normoxic and hypoxic conditions. FEBS Lett (2005) 1.13

The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer. FEBS J (2013) 1.13

Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1. FASEB J (2010) 1.13

Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease. PLoS One (2010) 1.11

Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol (2008) 1.11

Protein transport into the endoplasmic reticulum: mechanisms and pathologies. Trends Mol Med (2006) 1.10

Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma. Int J Cancer (2012) 1.10

Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy. BMC Cancer (2013) 1.10

WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier. J Am Soc Nephrol (2011) 1.10

Renal tubular HIF-2α expression requires VHL inactivation and causes fibrosis and cysts. PLoS One (2012) 1.09

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. Cancer Immunol Immunother (2009) 1.08

Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition. Hypertension (2004) 1.08

Podocytes are nonhematopoietic professional antigen-presenting cells. J Am Soc Nephrol (2013) 1.07

Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products. J Am Soc Nephrol (2005) 1.07

HIF-prolyl hydroxylases in the rat kidney: physiologic expression patterns and regulation in acute kidney injury. Am J Pathol (2009) 1.06

Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury. J Am Soc Nephrol (2011) 1.05

Mammographic density as a risk factor for breast cancer in a German case-control study. Eur J Cancer Prev (2011) 1.05

Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells. Int J Cancer (2011) 1.02

Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing. Mol Cancer Res (2013) 1.02

A complex microdeletion 17q12 phenotype in a patient with recurrent de novo membranous nephropathy. BMC Nephrol (2012) 1.02

Glomerular and renal vascular structural changes in alpha8 integrin-deficient mice. J Am Soc Nephrol (2003) 1.01

Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature. J Am Soc Nephrol (2004) 1.01

Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp Rats. J Am Soc Nephrol (2004) 1.00

Complement factor H-related hybrid protein deregulates complement in dense deposit disease. J Clin Invest (2013) 1.00

15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment. Anticancer Res (2011) 0.99

Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial. Breast Cancer Res Treat (2010) 0.98

Morphology of the heart and arteries in renal failure. Kidney Int Suppl (2003) 0.98

High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy. PLoS One (2011) 0.98

Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer. Mol Cancer (2007) 0.98

High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice. Eur J Immunol (2011) 0.98

Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells. BMC Urol (2008) 0.98

What you should know about the work-up of a renal biopsy. Nephrol Dial Transplant (2006) 0.97

Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation. Transpl Int (2009) 0.97

Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors. J Am Soc Nephrol (2003) 0.97

Comparison of total laparoscopic hysterectomy (TLH) and laparoscopy-assisted supracervical hysterectomy (LASH) in women with uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol (2009) 0.97

Prenatal programming-effects on blood pressure and renal function. Nat Rev Nephrol (2011) 0.97

Increased infarct size in uremic rats: reduced ischemia tolerance? J Am Soc Nephrol (2004) 0.97

Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction. Hypertension (2011) 0.97

ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cells. Kidney Int (2002) 0.97

Differential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2011) 0.96

CXCL16 and oxLDL are induced in the onset of diabetic nephropathy. J Cell Mol Med (2009) 0.96

Autonomic renal denervation ameliorates experimental glomerulonephritis. J Am Soc Nephrol (2008) 0.96

Renal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust fibre amosite. J Cell Mol Med (2008) 0.96

Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker. Lab Invest (2003) 0.95

Encapsulating peritoneal sclerosis - an overview. Nephrol Ther (2011) 0.94

Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome. Mol Reprod Dev (2008) 0.93

Application of a modified real-time PCR technique for relative gene copy number quantification to the determination of the relationship between NKX3.1 loss and MYC gain in prostate cancer. Clin Chem (2005) 0.93

CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. Am J Pathol (2009) 0.92